Krystal Biotech Inc (KRYS)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 61.25% | 57.79% | 42.28% | 4.21% | -70.11% | -793.89% | -3,836.53% | -10,340.17% | — | — | — | — | — | — | — | — | — | — | — | -1,369.37% |
| Operating profit margin | 22.39% | 11.08% | -12.16% | -65.11% | -188.68% | -1,348.76% | -6,405.56% | -17,774.78% | — | — | — | — | — | — | — | — | — | — | — | -4,304.80% |
| Pretax margin | 32.51% | 23.17% | 62.83% | 56.96% | 22.18% | -272.36% | -5,874.85% | -16,725.22% | — | — | — | — | — | — | — | — | — | — | — | -3,748.71% |
| Net profit margin | 30.39% | 21.14% | 61.41% | 55.06% | 18.80% | -272.36% | -5,874.85% | -16,725.22% | — | — | — | — | — | — | — | — | — | — | — | -3,748.71% |
Based on the provided data, Krystal Biotech Inc's profitability ratios have shown significant fluctuations over the years. The gross profit margin for the company was notably negative in the earlier periods, notably at -10,340.17% on March 31, 2023. However, there has been a positive turnaround since then, with the gross profit margin standing at 61.25% on December 31, 2024, indicating an improvement in the company's ability to generate profits from its core operations.
Similarly, the operating profit margin and pretax margin also exhibited negative figures in the past but have shown improvement in recent periods. For instance, the operating profit margin was -17,774.78% on March 31, 2023, but increased to 22.39% on December 31, 2024. The pretax margin followed a similar trend, from -16,725.22% on March 31, 2023, to 32.51% on December 31, 2024. These improvements suggest that Krystal Biotech Inc has been able to better control its operating and pre-tax expenses, resulting in higher profitability.
Furthermore, the net profit margin also has gradually increased from negative figures in earlier periods to positive values in recent years, indicating the company's ability to generate profits after accounting for all expenses including taxes. The net profit margin improved from -16,725.22% on March 31, 2023, to 30.39% on December 31, 2024.
Overall, the trend in profitability ratios for Krystal Biotech Inc shows a positive direction, with significant improvements in its margins over the years, reflecting better financial health and operational efficiency.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 6.22% | 2.79% | -2.29% | -7.92% | -13.41% | -18.68% | -22.38% | -27.04% | -26.00% | -22.95% | -19.37% | -16.88% | -10.90% | -12.60% | -11.46% | -9.35% | -10.62% | -9.23% | -7.67% | -11.37% |
| Return on assets (ROA) | 8.44% | 5.33% | 11.54% | 6.70% | 1.34% | -3.77% | -20.53% | -25.44% | -25.06% | -22.51% | -19.20% | -16.81% | -11.11% | -12.89% | -11.76% | -9.62% | -10.35% | -8.71% | -6.85% | -9.90% |
| Return on total capital | 6.94% | 3.10% | -2.50% | -8.46% | -14.09% | -19.53% | -23.44% | -29.37% | -27.80% | -24.47% | -20.83% | -18.99% | -11.50% | -13.92% | -12.15% | -9.61% | -11.30% | -9.52% | -7.88% | -11.76% |
| Return on equity (ROE) | 9.42% | 5.91% | 12.63% | 7.15% | 1.40% | -3.94% | -21.50% | -27.64% | -26.80% | -23.99% | -20.65% | -18.91% | -11.72% | -14.24% | -12.46% | -9.90% | -11.01% | -9.00% | -7.04% | -10.24% |
Krystal Biotech Inc's profitability ratios have exhibited fluctuations over the periods analyzed. The Operating Return on Assets (Operating ROA) ranged from -27.04% on March 31, 2023, to 6.22% on December 31, 2024. Similarly, the Return on Assets (ROA) fluctuated from -25.44% on March 31, 2023, to 11.54% on June 30, 2024. Return on Total Capital varied from -29.37% on March 31, 2023, to 6.94% on December 31, 2024. Meanwhile, Return on Equity (ROE) showed a range from -27.64% on March 31, 2023, to 12.63% on June 30, 2024.
The negative values in the profitability ratios indicate that the company may not have been efficiently utilizing its assets and capital to generate profits during those periods. However, the positive values seen in the latter periods signify an improvement in the company's ability to generate returns for its shareholders. Overall, analyzing these ratios can provide insights into Krystal Biotech Inc's financial performance and efficiency in generating profits for investors.